Depakote ER for manic episodes in bipolarity type I
This study is completed in the United States. It is testing Depakote ER for manic episodes in bipolarity type I.
BipolarityDrugFrom 10 Years to 17 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Divalproex Sodium (Depakote ER) may be useful for adolescents experiencing bipolarity.
What would participation involve?
Participants may receive Divalproex Sodium (Depakote ER), attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adolescents with bipolarity. Because it involves minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 29 sites
PCSD Feighner Research
San Diego, California
Site status: Not listed — confirm with the team
PCSD Feighner Research
San Marcos, California
Site status: Not listed — confirm with the team
Altamonte Springs
Altamonte Springs, Florida
Site status: Not listed — confirm with the team
Segal Institute for Clinical Research
Fort Lauderdale, Florida
Site status: Not listed — confirm with the team
Sarkis Clinical Trials
Gainesville, Florida
Site status: Not listed — confirm with the team
Segal Institute for Clinical Research
North Miami, Florida
Site status: Not listed — confirm with the team
Kolin Research Group
Winter Park, Florida
Site status: Not listed — confirm with the team
Northlake Medical Research Center
Decatur, Georgia
Site status: Not listed — confirm with the team
Mountain West Clinical Trials
Eagle, Idaho
Site status: Not listed — confirm with the team
Capstone Clinical Research
Libertyville, Illinois
Site status: Not listed — confirm with the team
Clinco
Terre Haute, Indiana
Site status: Not listed — confirm with the team
Cientifica Inc.
Newton, Kansas
Site status: Not listed — confirm with the team
Psychiatric Associates
Overland Park, Kansas
Site status: Not listed — confirm with the team
Brentwood Research Institute
Shreveport, Louisiana
Site status: Not listed — confirm with the team
Acadia Hospital
Bangor, Maine
Site status: Not listed — confirm with the team
Pharmasite Research
Baltimore, Maryland
Site status: Not listed — confirm with the team
North Carolina Neuropsychiatry, PA
Chapel Hill, North Carolina
Site status: Not listed — confirm with the team
Odyssey Research
Fargo, North Dakota
Site status: Not listed — confirm with the team
Neuro Behavioral Clinical Research, INC.
Canton, Ohio
Site status: Not listed — confirm with the team
Psychiatric Professional Services
Cincinnati, Ohio
Site status: Not listed — confirm with the team
Rakesh Ranjan, M.D. & Associates, Inc.
Lyndhurst, Ohio
Site status: Not listed — confirm with the team
IPS Research
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Cutting Edge Research Group
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Clinical Trials Specialists
Bala-Cynwyd, Pennsylvania
Site status: Not listed — confirm with the team
UTHSC, Sept. of Psychiatry, College of Medicine
Memphis, Tennessee
Site status: Not listed — confirm with the team
InSite Clinical Research
DeSoto, Texas
Site status: Not listed — confirm with the team
Red Oak Psychiatry
Houston, Texas
Site status: Not listed — confirm with the team
R/D Clinical Research
Lake Jackson, Texas
Site status: Not listed — confirm with the team
Northwest Clinical Research Center
Bellevue, Washington
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00195780. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Divalproex Sodium (Depakote ER). Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: From 10 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Abbott, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
